NCT06388486

Brief Summary

The goal of this observational study is to measure the levels of cytokine-induced transcription factor activation in a cohort of depressed inpatients undergoing psychotherapy. The study aims to answer the following main questions:

  • Do psychological traits (i.e.: social inhibition, negative affectivity, ...) affect the activation of immunomodulatory transcription factors (STAT3, NFkB) in depressed patients?
  • Are subjects with these psychological traits affected differently by psychotherapeutic intervention? Study subjects are assessed for their psychological and behavioral traits and receive psychotherapeutic care over several weeks during hospital treatment. Peripheral blood mononuclear cells are isolated from the study subjects, and activation of transcription factors is measured by flow cytometry.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

5.2 years

First QC Date

April 23, 2024

Last Update Submit

April 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in depression

    Hospital Depression and Anxiety Scale (HADS). The HADS instrument is a 14-item scale, with seven items relating to anxiety and seven relating to depression item. Each item on qestionnaire is scored from 0-3 resulting in a score between 0 and 21 for either anxiety or depression with higher scores meaning a worse outcome.

    6 weeks

Interventions

PsychotherapyBEHAVIORAL

Subject receive psychotherapy during hospital treatment.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Depressed inpatients, admitted for multimodal treatment, including psychotherapy.

You may qualify if:

  • Diagnosis of current depression

You may not qualify if:

  • inadequate knowledge of the German language
  • unable to give informed consent
  • severe psychiatric comorbidities, such as drug abuse and psychotic diseases
  • deemed critically unstable by their treating physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression

Interventions

Psychotherapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, Head of the Molecular Psychocardiology laboratory

Study Record Dates

First Submitted

April 23, 2024

First Posted

April 29, 2024

Study Start

January 1, 2017

Primary Completion

March 9, 2022

Study Completion

January 1, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share